Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Clinical Laserthermia Systems will receive ca SEK 23.5 million in connection with the warrant exercise and underwriting commitments for TO 6 B, corresponding to a subscription rate of 100 percent.

Lund, Sweden - On February 6, 2024, the exercise period ended for warrants of series TO 6 B that were issued in connection with Clinical Laserthermia Systems AB's ("CLS" or "the Company") preferential rights issue of units that was resolved on at the extraordinary general meeting on June 8, 2023 ("TO 6 B"). A total of 189,182,414 TO 6 B was exercised, corresponding to a subscription rate of approximately 80.7 percent. During the exercise period, the Company agreed on underwriting commitments (so-called "top-down" or "top guarantee") of TO 6 B, which are thus activated in order to achieve the

Invitation to Press Conference "Delivering net-zero shipping by 2050: Introducing the Green Balance Mechanism"

The global shipping regulator, the UN International Maritime Organisation, has set a target of net-zero carbon emissions by 2050 for the industry, and now needs to develop climate regulations by 2025 that make it possible to reach that target. One of the core challenges is how to craft a global greenhouse gas pricing regulation that can bridge the price gap between the cleanest fuels and fossil fuels, driving investments in renewable fuels, without imposing an outsized cost on the global economy.As member nations are preparing for climate negotiations at MEPC 81, the World Shipping Council

Onfido enters exclusive discussions with potential acquirer

7 February 2024   Augmentum Fintech plc Portfolio Update: Onfido enters exclusive discussions with potential acquirer Augmentum Fintech plc (LSE: AUGM) (the “Company”), Europe’s leading publicly listed fintech fund, notes the announcement today that portfolio company Onfido has entered exclusive discussions with potential acquirer, US based Entrust, a global leader in trusted payments, identities and data security. If this transaction goes ahead we expect the proceeds to be at or slightly above the current holding value, and it will be Augmentum’s sixth portfolio investment exit.

Male sex, high age, little physical exercise and low level of education are associated with allostatic load

Allostatic load refers to a disorder of the body’s stress response, which has been shown to increase the risk of mortality and various health risks, as well as being associated with mental disorders. A recent study by the University of Eastern Finland explored the associations of allostatic load with depressive symptoms, lifestyles, health behaviors and sociodemographic factors, such as age and level of education. The study found that the older the study participant, the higher their allostatic load. In addition, depressive symptoms, male sex, not engaging in physical exercise, high

Balder’s associated company Next Step Group in major collaboration to boost Sweden's competitiveness in sustainable mobility

Vectura Fastigheter and Fastighets AB Balder’s associated company Next Step Group continue to invest, now in collaboration with Volvo Cars and Gothenburg City, to contribute to Sweden's international competitiveness. The companies plan to create a leading innovation cluster in sustainable mobility.The first property to undergo transformation into Mobility Innovation Destination Torslanda has already been initiated – serving as a hub for tomorrow's mobility solutions. “This is a great investment opportunity that we are proud to be a part of. Together with Volvo Cars and Vectura, we want

CDP recognises Metsä Board with a ‘A’ score for transparency on climate change and water security

Metsä Board Corporation press release 07.02.2024Metsä Board, part of Metsä Group, has been recognised for leadership in corporate transparency and performance on climate change and water security by global environmental non-profit CDP, retaining a place on its annual A List. Based on data reported through CDP’s 2023 Climate Change and Water Security questionnaires, Metsä Board is one of a small number of companies that achieved a double A, out of 23,000 companies scored. In the Forests questionnaire Metsä Board scored an A-. “We have ambitious sustainability targets including 100% fossil

FREYR Battery Provides Operations and Financial Update

News Release FREYR Battery Provides Operations and Financial Update · FREYR reaches major milestone by successfully conducting automated casting trials of electrodes with active electrolyte slurry at Customer Qualification Plant · FREYR expects to make functional battery cells for customer samples using full automation of CQP in H1 2024, which is the Company’s top strategic priority · FREYR expects to submit Part 2 of its Title 17 application to U.S. Department of Energy Loan Programs Office in Q1 2024 · Year-end 2023 cash and equivalents balance of $275.7 million

Notice convening the Annual General Meeting of Valmet Oyj

Notice convening the Annual General Meeting of Valmet Oyj Valmet Oyj’s stock exchange release on February 7, 2024 at 1:05 p.m. EET   Notice is given to the shareholders of Valmet Oyj (“Valmet” or the “Company”) to the Annual General Meeting to be held on March 21, 2024 starting at 1:00 p.m. (EET) at Siipi Conference Centre of Helsinki Expo and Convention Centre (Messukeskus Helsinki), hall 101 at the address Rautatieläisenkatu 3, 00520 Helsinki, Finland. The reception of the shareholders who have registered for the meeting and the distribution of voting tickets will commence at 12:

Glaston publishes the 2023 Financial Statements Bulletin on 15 February 2024, at 8.30 a.m.

Glaston Corporation     Press release      7.2.2024 at 13.00Glaston Corporation will publish its January−December 2023 Financial Statements Bulletin on Thursday, 15 February 2024 at around 8.30 a.m. Finnish time. The Financial Statements Bulletin and presentation will be available as soon as possible after publishing on the Company’s internet pages at www.glaston.net.Glaston’s Interim CEO Antti Kaunonen and CFO Päivi Lindqvist will present the financial result to analysts, investors and media representatives on the same day at 9.30 (Finnish time) in English. The live webcast can be joined

BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Severe Respiratory Infections

Bergen, Norway, February 7, 2024, – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that Dr. Mirella Spalluto of the University of Southampton today presented “Investigating the effects of AXL inhibition during respiratory viral infections” during the 6th Forum on Respiratory Infections in Glasgow, Scotland. The data presented by Dr. Spalluto showed bemcentinib had activity in human in vitro models of infection caused by Respiratory Syncytial Virus (RSV), influenza and

Year end report 2023

2023 ended with increased rental income, improved operating income, strengthened surplus ratio and improved management result. Net letting amounted to SEK 165m, one of the strongest ever for Fabege. Higher interest costs and negative value changes in the property portfolio meant that the result after tax decreased compared to the previous year.· Rental income increased to SEK 3,336m (3,032). On a like-for-like basis, rental income increased by just over 11 per cent (5). · Net operating income increased to SEK 2,524m (2,240). On a like-for-like basis, net operating income increased by 14

Valmet’s Financial Statements Review January 1 – December 31, 2023: Orders received amounted close to EUR 5.0 billion and Comparable EBITA increased to EUR 619 million in 2023

Valmet’s Financial Statements Review January 1 – December 31, 2023: Orders received amounted close to EUR 5.0 billion and Comparable EBITA increased to EUR 619 million in 2023 Valmet Oyj’s stock exchange release on February 7, 2024 at 1:00 p.m. EET Figures in brackets, unless otherwise stated, refer to the comparison period, i.e., the same period of the previous year. October–December 2023: Net sales remained at the previous year's level, Comparable EBITA decreased •         Orders received decreased 17 percent to EUR 1,155 million (EUR 1,385 million). –        Orders

Impala Bondco plc - Initiates a written procedure and provides financial updates

Nottingham, 7 February 2024 - Impala Bondco Plc (the "Company") has instructed the agent for the Company's up to SEK 500,000,000 senior secured bonds with ISIN NO0011117145 (the "Bonds") to initiate a written procedure to request the holders of the Bonds to, amongst other things, vote in favour of amending the terms and conditions of the Bonds (the "Terms and Conditions"). As announced on 19 January 2024, the Company has not made its latest scheduled payments of interest under the Bonds resulting in the occurrence of an event of default under the terms and conditions of the Bonds (the "

Konecranes’ climate work earns Leadership ranking from the CDP for a second consecutive year

Konecranes received an A- rating in the annual climate program of the CDP for a second straight year, reflecting its efforts and commitment to be a material handling industry leader in cutting emissions, managing and mitigating climate risks and developing a low-carbon offering. The CDP’s annual program is a globally recognized benchmark that ranks the efforts of investors, companies, cities, states and regions to manage their environmental impact. Companies receiving a Leadership ranking must demonstrate both awareness of their impact on the environment, and the appropriate actions

Salmon Evolution ASA: Invitation to presentation of results for the fourth quarter 2023

Salmon Evolution will present the fourth quarter 2023 results followed by a Q&A session, on Tuesday 13 February 2024 08:00 CET, at Hotel Continental in Oslo. A light snack will be served from 07:45 CET. Participants may also follow the presentation and submit questions through a live webcast available on www.salmonevolution.no, or with the following link: https://events.webcast.no/salmon-evolution/OEpmPDaoyhi5siPjdg0b/4XiwthqLH2GoUCaGlEfL The presentation and Q&A will be held in English by CEO Trond Håkon Schaug-Pettersen and CFO Trond Vadset Veibust. Please note that the quarterly

Blocklisting - Interim Review

BLOCK LISTING SIX MONTHLY RETURN   Information provided on this form must be typed or printed electronically and provided to an ris.   Date: 7 February 2024   +---------+-----+-------------+---+-------------------+|Name of |Fidelity Special Values PLC ||applicant: | |+---------+-----+-------------+---+-------------------+|Name of |General Corporate Purposes ||scheme: | |+---------+-----+-------------+---+-------------------+|Period of|From:|8

1Vision Biogas publishes supplement to the offer document regarding the mandatory cash offer to the shareholders of Biokraft

The Offer is not being made, and this press release may not be released, distributed or published, in whole or in part, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in, the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa, South Korea, Russia, Belarus or any other jurisdiction in which the making of the Offer, the release, distribution or publication of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer

Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

Oslo, 7 February 2024: Reference is made to the stock exchange announcement by Circio Holding ASA (OSE:CRNA) (“CIRCIO” or the “Company“) on 5 February 2024, regarding the requested conversion of convertible bonds by Atlas Special Opportunities, LLC. The share capital increase has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The Company’s new share capital is NOK 4,660,284.60 divided into 7,767,141 shares, each with a nominal value of NOK 0.60.

Highlights of Stadshypotek’s Annual Report January–December 2023

JANUARY–DECEMBER 2023 COMPARED WITH JANUARY–DECEMBER 2022Stadshypotek’s operating profit decreased by SEK 3,589m, or 28%, to SEK 9,298m (12,887). Net interest income fell by SEK 2,767m to SEK 12,212m, (14,979), mainly due to higher funding costs arising from rising market rates, and decreased margins for Swedish and Norwegian private loans. In Sweden, net interest income fell by SEK 2,020m, while in the Norwegian branch it fell by SEK 164m.   Of the net interest income, SEK 688m (852) was attributable to the branch in Norway and SEK 469m (557) to the branch in Finland. Exclud- ing the

SAS Traffic figures – January 2024

1.5 million passengers traveled with SAS during January1.5 million passengers traveled with SAS in January, a 1 percent increase compared with the same month last year. SAS’ capacity increased by 5 percent and RPK increased by 9 percent, compared with January 2023. The flown load factor for January was 70 percent. “We are pleased to see that more and more people choose to travel with SAS. To meet the increasing demand for travel, we released our summer program in January, adding several new and exciting destinations in Scandinavia, Europe and the US. We also announced a new collaboration

Essity included in S&P Global’s Sustainability Yearbook 2024

Hygiene and health company Essity has, for the third consecutive year, been included in S&P Global’s Sustainability Yearbook. In the review of more than 9,400 companies worldwide, Essity is part of the top 10% to be selected for this year’s Yearbook.S&P Global is an international finance and analytics company that annually reviews the world’s most sustainable companies. Each company answers a comprehensive questionnaire that is analyzed alongside public environmental, social and governance (ESG) data.  “Every day, over a billion people use our products, services and solutions. Thanks to

OncoZenge Files Patent Application for Strengthened IP Protection for BupiZenge™

Stockholm, February 7, 2024 – OncoZenge AB (publ) today announces that the company has filed a new patent application with the Swedish Patent and Registration Office (PRV). The patent strengthens the protection of the second generation of BupiZenge™ and the innovations made in connection with the recent reformulation. The new patent will provide strengthened IP protection for strategic partners and licensees upon approval.In line with OncoZenge's strategy, the company has assessed the opportunities for complementary patents that further strengthen the protection for the second generation

BiBB Receives European CE Mark Approval According to MDR for the Entire EndoDrill Product Family

The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company"), which has developed the world's first electric-driven endoscopic biopsy instrument, announces that the Company has received CE certification for EndoDrill[®] in accordance with MDR. The market approval allows EndoDrill[®] to be introduced in Europe for all three market segments, i.e. for sampling of the gastrointestinal tract, lungs, and bladder. With the CE mark in place, the Company plans to launch EndoDrill® GI in 2024 to targeted customers. Several clinical market studies are also planned to highlight the

Researchers trialling new device to support amputees

A new medical device developed by Teesside University researchers in a pioneering project could be used to treat phantom limb pain.Teesside University collaborated with healthcare innovation company 2PD to design and develop a new medical device which could support people who have had  amputation surgery. Now completed, the device is undergoing a clinical trial to investigate its efficacy in treating phantom limb pain. Phantom limb pain occurs when amputees experience sensations which feel like they are coming from an amputated limb. It can be seriously debilitating and is a common

There are no items matching the current filter
There are no more items matching the current filter
Back to top